inositol has been researched along with Complications, Pregnancy in 15 studies
Inositol: An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction.
inositol : Any cyclohexane-1,2,3,4,5,6-hexol.
1D-chiro-inositol : Belonging to the inositol family of compounds, D-chiro-inositol (DCI) is an isomer of glucose. It is an important secondary messenger in insulin signal transduction.
muco-inositol : An inositol that is cyclohexane-1,2,3,4,5,6-hexol having a (1R,2R,3r,4R,5S,6r)-configuration.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Inositols (INOs) supplementation during pregnancy, specifically the combination of myo-inositol (MI) and D-chiro-inositol (DCI), has been reported to improve vascular parameters in women with gestational diabetes mellitus." | 7.91 | Vascular and metabolic profiles in offspring born to pregnant mice with metabolic syndrome treated with inositols. ( Alrais, M; Blackwell, SC; Facchinetti, F; Ferrari, F; Longo, M; Refuerzo, JS; Sibai, BM; Tamayo, EH, 2019) |
| "Authors would like to demonstrate the beneficial effect of myo-inositol supplementation in a pregnant woman with insulin-dependent type 2 diabetes mellitus and polycystic ovary syndrome." | 7.85 | [The myo-inositol is beneficial in the therapy of pregnancy with insulin-dependent type 2 diabetes and polycystic ovary syndrome]. ( Kun, A; Tornóczky, J, 2017) |
| "Myoinositol and D-chiroinositol improve insulin resistance in women with obesity and gestational diabetes and in postmenopausal women with metabolic syndrome." | 7.83 | The effect of combined inositol supplementation on maternal metabolic profile in pregnancies complicated by metabolic syndrome and obesity. ( Blackwell, SC; Facchinetti, F; Ferrari, F; Longo, M; Ontiveros, AE; Refuerzo, JS; Roberts, RP; Saade, MM; Sibai, BM, 2016) |
| "To investigate myo-inositol, glucose and zinc status in mothers and their infants on cleft lip with or without cleft palate risk (CLP)." | 7.72 | Myo-inositol, glucose and zinc status as risk factors for non-syndromic cleft lip with or without cleft palate in offspring: a case-control study. ( Brussel, W; Krapels, IP; Rooij, IA; Spauwen, PH; Steegers-Theunissen, RP; Wevers, RA; Zielhuis, GA, 2004) |
| "Inositols (INOs) supplementation during pregnancy, specifically the combination of myo-inositol (MI) and D-chiro-inositol (DCI), has been reported to improve vascular parameters in women with gestational diabetes mellitus." | 3.91 | Vascular and metabolic profiles in offspring born to pregnant mice with metabolic syndrome treated with inositols. ( Alrais, M; Blackwell, SC; Facchinetti, F; Ferrari, F; Longo, M; Refuerzo, JS; Sibai, BM; Tamayo, EH, 2019) |
| "Authors would like to demonstrate the beneficial effect of myo-inositol supplementation in a pregnant woman with insulin-dependent type 2 diabetes mellitus and polycystic ovary syndrome." | 3.85 | [The myo-inositol is beneficial in the therapy of pregnancy with insulin-dependent type 2 diabetes and polycystic ovary syndrome]. ( Kun, A; Tornóczky, J, 2017) |
| "Myoinositol and D-chiroinositol improve insulin resistance in women with obesity and gestational diabetes and in postmenopausal women with metabolic syndrome." | 3.83 | The effect of combined inositol supplementation on maternal metabolic profile in pregnancies complicated by metabolic syndrome and obesity. ( Blackwell, SC; Facchinetti, F; Ferrari, F; Longo, M; Ontiveros, AE; Refuerzo, JS; Roberts, RP; Saade, MM; Sibai, BM, 2016) |
| "To evaluate retrospectively the prevalence of gestational diabetes (GD) in pregnancies obtained with myo-inositol administration in women with polycystic ovary syndrome." | 3.78 | Myo-inositol may prevent gestational diabetes in PCOS women. ( Corrado, F; D'Anna, R; Di Benedetto, A; Di Benedetto, V; Interdonato, ML; Raffone, E; Rizzo, P, 2012) |
| "To investigate myo-inositol, glucose and zinc status in mothers and their infants on cleft lip with or without cleft palate risk (CLP)." | 3.72 | Myo-inositol, glucose and zinc status as risk factors for non-syndromic cleft lip with or without cleft palate in offspring: a case-control study. ( Brussel, W; Krapels, IP; Rooij, IA; Spauwen, PH; Steegers-Theunissen, RP; Wevers, RA; Zielhuis, GA, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 7 (46.67) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Plows, JF | 1 |
| Ramos Nieves, JM | 1 |
| Budin, F | 1 |
| Mace, K | 1 |
| Reynolds, CM | 1 |
| Vickers, MH | 1 |
| Silva-Zolezzi, I | 1 |
| Baker, PN | 1 |
| Stanley, JL | 1 |
| Kun, A | 1 |
| Tornóczky, J | 1 |
| Longo, M | 2 |
| Alrais, M | 1 |
| Tamayo, EH | 1 |
| Ferrari, F | 2 |
| Facchinetti, F | 2 |
| Refuerzo, JS | 2 |
| Blackwell, SC | 2 |
| Sibai, BM | 2 |
| Metges, CC | 1 |
| Görs, S | 1 |
| Lang, IS | 1 |
| Hammon, HM | 1 |
| Brüssow, KP | 1 |
| Weitzel, JM | 1 |
| Nürnberg, G | 1 |
| Rehfeldt, C | 1 |
| Otten, W | 1 |
| Li, Q | 1 |
| Leung, YO | 1 |
| Zhou, I | 1 |
| Ho, LC | 1 |
| Kong, W | 1 |
| Basil, P | 1 |
| Wei, R | 1 |
| Lam, S | 1 |
| Zhang, X | 1 |
| Law, AC | 1 |
| Chua, SE | 1 |
| Sham, PC | 1 |
| Wu, EX | 1 |
| McAlonan, GM | 1 |
| Ontiveros, AE | 1 |
| Roberts, RP | 1 |
| Saade, MM | 1 |
| D'Anna, R | 1 |
| Di Benedetto, V | 1 |
| Rizzo, P | 1 |
| Raffone, E | 1 |
| Interdonato, ML | 1 |
| Corrado, F | 1 |
| Di Benedetto, A | 1 |
| Staat, BC | 1 |
| Galan, HL | 1 |
| Harwood, JE | 1 |
| Lee, G | 1 |
| Marconi, AM | 1 |
| Paolini, CL | 1 |
| Cheung, A | 1 |
| Battaglia, FC | 1 |
| BALESTRI, F | 1 |
| BONINO, A | 1 |
| Krapels, IP | 1 |
| Rooij, IA | 1 |
| Wevers, RA | 1 |
| Zielhuis, GA | 1 |
| Spauwen, PH | 1 |
| Brussel, W | 1 |
| Steegers-Theunissen, RP | 1 |
| Gojnic, M | 1 |
| Pervulov, M | 1 |
| Burton, LE | 2 |
| Wells, WW | 2 |
| Brivet, M | 1 |
| Migayron, F | 1 |
| Roger, J | 1 |
| Cheron, G | 1 |
| Lemonnier, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT01511822] | Phase 4 | 0 participants | Interventional | Completed | |||
| Reduction of Insulin Therapy Under Myo-inositol for the Treatment of Gestational Diabetes Mellitus: a Randomized Multicenter and Prospective Trial. MYO-GDM Study[NCT03875755] | 1,080 participants (Anticipated) | Interventional | 2020-03-04 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for inositol and Complications, Pregnancy
| Article | Year |
|---|---|
Artificial fetal lung maturation--prevention of antenatal complications in premature deliveries.
Topics: Adrenergic beta-Agonists; Aminophylline; Bronchodilator Agents; Drug Administration Schedule; Female | 2005 |
1 trial available for inositol and Complications, Pregnancy
| Article | Year |
|---|---|
Transplacental supply of mannose and inositol in uncomplicated pregnancies using stable isotopes.
Topics: Adult; Carbon Isotopes; Cesarean Section; Female; Humans; Hydrogen; Infant, Newborn; Inositol; Isoto | 2012 |
13 other studies available for inositol and Complications, Pregnancy
| Article | Year |
|---|---|
The effects of myo-inositol and probiotic supplementation in a high-fat-fed preclinical model of glucose intolerance in pregnancy.
Topics: Adipose Tissue; Animals; Blood Glucose; Diabetes, Gestational; Diet, High-Fat; Dietary Supplements; | 2020 |
[The myo-inositol is beneficial in the therapy of pregnancy with insulin-dependent type 2 diabetes and polycystic ovary syndrome].
Topics: Adult; Diabetes Mellitus, Type 1; Female; Humans; Infant, Newborn; Inositol; Polycystic Ovary Syndro | 2017 |
Vascular and metabolic profiles in offspring born to pregnant mice with metabolic syndrome treated with inositols.
Topics: Animals; Biomarkers; Drug Administration Schedule; Female; Hypertension; Inositol; Male; Metabolic S | 2019 |
Low and high dietary protein:carbohydrate ratios during pregnancy affect materno-fetal glucose metabolism in pigs.
Topics: Adaptation, Physiological; Animals; Area Under Curve; Blood Glucose; Brain; Diet; Diet, Carbohydrate | 2014 |
Dietary supplementation with n-3 fatty acids from weaning limits brain biochemistry and behavioural changes elicited by prenatal exposure to maternal inflammation in the mouse model.
Topics: Animals; Aspartic Acid; Behavior, Animal; Creatine; Diet, High-Fat; Dietary Supplements; Fatty Acids | 2015 |
The effect of combined inositol supplementation on maternal metabolic profile in pregnancies complicated by metabolic syndrome and obesity.
Topics: Animals; Biomarkers; Blood Glucose; Dietary Supplements; Disease Models, Animal; Female; Gastric Inh | 2016 |
Myo-inositol may prevent gestational diabetes in PCOS women.
Topics: Adult; Diabetes, Gestational; Female; Humans; Hypoglycemic Agents; Inositol; Metformin; Polycystic O | 2012 |
Myo-inositol may prevent gestational diabetes in PCOS women.
Topics: Adult; Diabetes, Gestational; Female; Humans; Hypoglycemic Agents; Inositol; Metformin; Polycystic O | 2012 |
Myo-inositol may prevent gestational diabetes in PCOS women.
Topics: Adult; Diabetes, Gestational; Female; Humans; Hypoglycemic Agents; Inositol; Metformin; Polycystic O | 2012 |
Myo-inositol may prevent gestational diabetes in PCOS women.
Topics: Adult; Diabetes, Gestational; Female; Humans; Hypoglycemic Agents; Inositol; Metformin; Polycystic O | 2012 |
[Treatment of hyperemesis gravidarum with combined inositol and pyridoxine].
Topics: Female; Humans; Hyperemesis Gravidarum; Inositol; Pregnancy; Pregnancy Complications; Pyridoxine; Vi | 1955 |
[Inositol in vomiting in pregnancy].
Topics: Female; Humans; Inositol; Pregnancy; Pregnancy Complications; Vomiting | 1956 |
Myo-inositol, glucose and zinc status as risk factors for non-syndromic cleft lip with or without cleft palate in offspring: a case-control study.
Topics: Adult; Blood Glucose; Case-Control Studies; Cleft Lip; Cleft Palate; Dietary Supplements; Erythrocyt | 2004 |
Characterization of the lactation-dependent fatty liver in myo-inositol deficient rats.
Topics: Animals; Cholesterol; Cholesterol Esters; Fatty Liver; Female; Inositol; Lactation; Lipid Metabolism | 1977 |
myo-Inositol metabolism during lactation and development in the rat. The prevention of lactation-induced fatty liver by dietary myo-inositol.
Topics: Amniotic Fluid; Animals; Body Weight; Disaccharides; Fatty Liver; Female; Galactose; Inositol; Lacta | 1976 |
Lens hexitols and cataract formation during lactation in a woman heterozygote for galactosaemia.
Topics: Adult; Cataract; Female; Galactitol; Galactokinase; Galactosemias; Genetic Carrier Screening; Humans | 1989 |